Today: 9 July 2026
BigBear.ai stock (BBAI) jumps as company moves to slash $125 million of convertible debt — what’s next
3 January 2026
2 mins read

BigBear.ai stock (BBAI) jumps as company moves to slash $125 million of convertible debt — what’s next

NEW YORK, January 3, 2026, 06:41 ET — Market closed

  • BigBear.ai said it has called its 6.00% convertible senior secured notes due 2029 for redemption, with the redemption date set for Jan. 16.
  • The company expects note-related debt to fall to about $17 million from about $142 million, largely through conversions into common stock.
  • BBAI closed Friday up 8.15% at $5.84 and was last down about 0.5% in after-hours trading.

BigBear.ai Holdings, Inc. (BBAI) said late Friday it has called its 6.00% convertible senior secured notes due 2029 for redemption, part of a plan to cut most of its note-related debt. BBAI shares closed up 8.15% at $5.84 and were last down about 0.5% after hours, according to MarketWatch data.

The move matters because convertible notes — debt that can be swapped for shares — can hang over small-cap stocks. They either dilute shareholders if converted, or hit cash if the issuer pays them back.

BigBear.ai is betting that turning debt into stock now will lower interest expense and reduce leverage. The trade-off is a bigger share count and a larger public float, the shares available for trading.

On Friday, the stock traded between $5.42 and $5.85 and changed hands about 56 million times, after opening at $5.60, according to MarketWatch historical data.

BigBear.ai said it expects to eliminate about $125 million of debt and reduce total note-related debt to about $17 million, leaving the remaining balance of its convertible notes due 2026. It said it expects to issue about 38 million shares that were reserved when the notes were issued, and it expects the transactions to be completed without any material cash outlay.

“Today’s announcement represents an important step in strengthening BigBear.ai’s long-term financial foundation,” Chief Executive Officer Kevin McAleenan said. BigBear.ai Holdings, Inc.

The balance-sheet move comes days after BigBear.ai finalized its $250 million cash acquisition of Ask Sage, which it described as a generative AI platform built for secure deployments in defense and other highly regulated environments. BigBear.ai said Ask Sage supports more than 100,000 users across 16,000 government teams and hundreds of commercial organizations.

Together, the Ask Sage deal and the note clean-up shift investor focus from financing risk to execution. BigBear.ai still needs to show it can translate high-security government use cases into scalable revenue without swelling costs.

That puts it in a crowded race for government AI budgets, where better-known defense and data-analytics vendors already pitch platforms designed for classified or tightly controlled environments.

Before the next U.S. session on Monday, traders will also watch early-January economic reports that can swing risk appetite for small-cap growth stocks. The U.S. jobs report is due Jan. 9 and the Consumer Price Index, a broad inflation gauge, is scheduled for Jan. 13; the Federal Reserve’s first policy meeting of 2026 runs Jan. 27–28.

BigBear.ai’s deadline is closer. A filing showed noteholders can convert until 5 p.m. New York time on the second scheduled trading day before the Jan. 16 redemption date, and the conversion rate — the number of shares issued per $1,000 of debt — is temporarily boosted to 305.5254 shares through Jan. 15.

Near term, technicians often look at “support” as a level where buyers tend to step in, and “resistance” as a level where sellers often emerge. For BBAI, Friday’s low near $5.42 is the first support, while the $5.85 area — and the $6 round-number above it — is the first resistance on the chart. StockAnalysis

On its investor calendar, the company lists a special meeting of stockholders scheduled for Jan. 22 at 3 p.m. EST. No earnings date appears on the upcoming-events list.

If conversions land as management expects, investors may treat the added shares as a one-off dilution event that clears an overhang. If noteholders choose cash instead, liquidity becomes the next question.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • Virax Biolabs Jumps 183% After UK Unit Signs Fosun Diagnostics Supply Deal
    July 9, 2026, 1:27 PM EDT. Shares of Virax Biolabs Group (NASDAQ: VRAX) soared 183% to $9.00 on July 9. The spike came after its UK arm reached an exclusive supply deal with Fosun Diagnostics covering Southeast Asia, including Thailand, Vietnam and Singapore. The agreement focuses on ImmuneSelect, its immune-profiling research product. Virax is looking to move past research-only offerings and grow in the commercial market. The company reported just $12,423 in revenue for fiscal 2026 and a net loss of $5 million. CEO James Foster called the deal a key step. Fosun MedTech, part of Fosun Pharma, which posted $5.8 billion in 2025 revenue, said Virax's platform is a strong research pick. The move follows a one-for-25 reverse split done to keep its Nasdaq listing.
Workday stock (WDAY) drops 4% to $205 as software names slide in 2026 debut
Previous Story

Workday stock (WDAY) drops 4% to $205 as software names slide in 2026 debut

Eli Lilly stock ends higher to start 2026 as traders eye JPM conference, earnings
Next Story

Eli Lilly stock ends higher to start 2026 as traders eye JPM conference, earnings

Go toTop